Activity of meropenem/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014-19).

Dee ShortridgeCecilia Godoy CarvalhaesLalitagauri DeshpandeMariana Castanheira

Published in: The Journal of antimicrobial chemotherapy (2021)

These in vitro data demonstrate that meropenem/vaborbactam has potent activity against isolates from PHP, including isolates producing KPC, and may be a useful treatment option for PHP, including VAP.

Keyphrases

gram negative
multidrug resistant
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
south africa
klebsiella pneumoniae
peritoneal dialysis
machine learning
patient reported outcomes
big data
escherichia coli
patient reported
smoking cessation
genetic diversity